Zhang et al., 2025 - Google Patents
ACSS2 mediates an epigenetic pathway to regulate β-cell adaptation during gestation in miceZhang et al., 2025
View HTML- Document ID
- 14562510040070009848
- Author
- Zhang Y
- He S
- Wang X
- Wang X
- He M
- Yu X
- Xu C
- Publication year
- Publication venue
- Nature Communications
External Links
Snippet
Maternal pancreatic β-cells undergo adaptive changes to meet the metabolic demands of pregnancy, and disruptions in this adaptation can lead to gestational diabetes mellitus. However, the mechanisms governing this adaptation remain largely unexplored. Using …
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | Spatiotemporal transcriptomic changes of human ovarian aging and the regulatory role of FOXP1 | |
| Tsukasaki et al. | Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution | |
| Dean et al. | Interrupted glucagon signaling reveals hepatic α cell axis and role for L-glutamine in α cell proliferation | |
| Ashraf et al. | Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment | |
| Chen et al. | A reinforcing HNF4–SMAD4 feed-forward module stabilizes enterocyte identity | |
| Neelankal John et al. | RNA-seq analysis of islets to characterise the dedifferentiation in type 2 diabetes model mice db/db | |
| Cai et al. | Indispensable role of the Ubiquitin-fold modifier 1-specific E3 ligase in maintaining intestinal homeostasis and controlling gut inflammation | |
| Zheng et al. | METTL3 is essential for normal progesterone signaling during embryo implantation via m6A-mediated translation control of progesterone receptor | |
| Wang et al. | Functional antagonism between ΔNp63α and GCM1 regulates human trophoblast stemness and differentiation | |
| Li et al. | Long noncoding RNA SAM promotes myoblast proliferation through stabilizing Sugt1 and facilitating kinetochore assembly | |
| Yang et al. | miR-125b enhances IL-8 production in early-onset severe preeclampsia by targeting sphingosine-1-phosphate lyase 1 | |
| Liang et al. | Modeling human thyroid development by fetal tissue‐derived organoid culture | |
| Gao et al. | Control of regional decidualization in implantation: Role of FoxM1 downstream of Hoxa10 and cyclin D3 | |
| Combes et al. | Haploinsufficiency for the Six2 gene increases nephron progenitor proliferation promoting branching and nephron number | |
| Bosma et al. | Pharmacological blockade of the EP3 prostaglandin E2 receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damage | |
| Luan et al. | The calcium channel subunit gamma-4 is regulated by MafA and necessary for pancreatic beta-cell specification | |
| Donti et al. | Screen for abnormal mitochondrial phenotypes in mouse embryonic stem cells identifies a model for succinyl-CoA ligase deficiency and mtDNA depletion | |
| Wen et al. | hnRNPU is required for spermatogonial stem cell pool establishment in mice | |
| Puri et al. | Sox9 regulates alternative splicing and pancreatic beta cell function | |
| Lee-Thacker et al. | Core Binding Factors are essential for ovulation, luteinization, and female fertility in mice | |
| Lei et al. | SRSF2 is required for mRNA splicing during spermatogenesis | |
| Raphael et al. | Activator protein transcription factors coordinate human IL-33 expression from noncanonical promoters in chronic airway disease | |
| Lin et al. | Aldo-keto reductase 1b7, a novel marker for renin cells, is regulated by cyclic AMP signaling | |
| Chen et al. | PARP1-catalyzed PARylation of YY1 mediates endoplasmic reticulum stress in granulosa cells to determine primordial follicle activation | |
| Zhang et al. | ACSS2 mediates an epigenetic pathway to regulate β-cell adaptation during gestation in mice |